EC devices man pays courtesy call on Canadian experts:
This article was originally published in Clinica
Executive Summary
Abraao Carvalho, the head of the European Commission's unit responsible for medical devices, cosmetics and the competitiveness of the pharmaceutical industry, has met with those responsible for medical devices at Health Canada. During a recent trip to Canada to deal with cosmetic issues, he also talked in general terms with the Canadian authorities about the principles of ongoing co-operation between the two markets, and the importance the EU attaches to this collaboration. The meeting also provided an opportunity to touch on issues concerning the global medical device vigilance system; Canada provides the secretariat for this system, while the EU currently holds the presidency of the EU Global Harmonisation Task Force.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.